These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10997326

  • 1. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
    Baur AS, Meugé-Moraw C, Schmidt PM, Parlier V, Jotterand M, Delacrétaz F.
    Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
    Oscier DG, Worsley A, Darlow S, Figes A, Williams JD, Hamblin TJ.
    Leuk Res; 1989 Feb; 13(9):833-9. PubMed ID: 2796388
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H, Hotta T, Ichihara M, Murate T, Kobayashi M, Saito H.
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
    Mangi MH, Mufti GJ.
    Blood; 1992 Jan 01; 79(1):198-205. PubMed ID: 1370203
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
    Chan GC, Wang WC, Raimondi SC, Behm FG, Krance RA, Chen G, Freiberg A, Ingram L, Butler D, Head DR.
    Leukemia; 1997 Feb 01; 11(2):206-11. PubMed ID: 9009082
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
    Kalina U, Hofmann WK, Koschmieder S, Wagner S, Kauschat D, Hoelzer D, Ottmann OG.
    Exp Hematol; 2000 Oct 01; 28(10):1158-63. PubMed ID: 11027834
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F, Krauth MT, Vales A, Böhm A, Agis H, Sonneck K, Aichberger KJ, Mayerhofer M, Simonitsch-Klupp I, Müllauer L, Sperr WR, Valent P.
    Leuk Lymphoma; 2006 Mar 01; 47(3):451-60. PubMed ID: 16396768
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K, Ohshima K, Suzumiya J, Kawasaki C, Kikuchi M.
    Br J Haematol; 2000 Sep 01; 110(3):584-90. PubMed ID: 10997968
    [Abstract] [Full Text] [Related]

  • 19. Clinical, hematological and histomorphological profile of myelodysplastic syndrome.
    Nigam S, Rani S, Singh T, Gupta S, Rakheja D, Gaiha M.
    J Assoc Physicians India; 2001 Apr 01; 49():430-4. PubMed ID: 11762613
    [Abstract] [Full Text] [Related]

  • 20. Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.
    Polychronopoulou S, Panagiotou JP, Kossiva L, Mavrou A, Anagnostou D, Haidas S.
    Acta Paediatr; 2004 Aug 01; 93(8):1015-23. PubMed ID: 15456186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.